Medicine
Aminocaproic acid 0.25 g/mL oral solution
Aminocaproic acid 0.25 g/mL oral solution is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Dispense in tight containers, Do Not Freeze. Store at 20° to 25°C (68° to…
Key facts
- Active ingredient (INN)
- Aminocaproic acid
- Brand
- Sold under the generic name
- Strength
- 0.25 g/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 236.5 mL, 473 mL, 10 cup and 11 more
- Manufacturers
- Novadoz PharmaceuticalsIndiaAurobindo PharmaIndiaBioconIndiaCamber PharmaceuticalsIndiaAmneal Pharmaceuticals NYApozeal PharmaceuticalsBPI LabsBryant Ranch PrepackCarnegie PharmaceuticalsFlorida Pharmaceutical Products
- Origin register
- US FDA, United States
- Storage
- Dispense in tight containers, Do Not Freeze. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B02AA01 Aminocaproic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 August 2019
- Identifiers
- RxCUI 582299DailyMed set ID cfa601c4-b649-417e-a301-b246f080f1eb, d9f615a0-119c-4553-93a7-b30025b5fe14, 828568a7-1808-4330-b466-01889b2311a2 +9NDC 54288-151, 69680-114, 71921-175 +9Application ANDA213825, ANDA213213, ANDA215510 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 236.5 mL in 1 bottle | 59651-573-08 | Aurobindo PharmaIndia | 26 September 2022 |
| 236.5 mL in 1 bottle | 70377-104-11 | BioconIndia | 18 March 2021 |
| 236.5 mL in 1 bottle, plastic | 31722-035-23 | Camber PharmaceuticalsIndia | 4 November 2022 |
| 236.5 mL in 1 bottle, plastic | 72205-032-71 | Novadoz PharmaceuticalsIndia | 1 January 2026 |
| 473 mL in 1 bottle, plastic | 72205-032-72 | Novadoz PharmaceuticalsIndia | 1 January 2026 |
| 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 69238-1596-4 | Amneal Pharmaceuticals NY | 23 August 2019 |
| 236.5 mL in 1 bottle, plastic | 69238-1596-8 | Amneal Pharmaceuticals NY | 23 August 2019 |
| 236.5 mL in 1 bottle | 83745-294-08 | Apozeal Pharmaceuticals | 10 November 2025 |
| 236.5 mL in 1 bottle, plastic | 54288-151-01 | Bpi Labs | 16 May 2022 |
| 236.5 mL in 1 bottle | 80005-130-22 | Carnegie Pharmaceuticals | 18 March 2021 |
| 236.5 mL in 1 bottle | 71921-175-08 | Florida Pharmaceutical Products | 20 December 2025 |
| 236.5 mL in 1 bottle, plastic | 52817-815-08 | TruPharma | 25 September 2020 |
| 236.5 mL in 1 bottle | 69680-114-08 | Vitruvias Therapeutics | 19 July 2024 |
| 236.5 mL in 1 bottle | 72162-2646-2 | Bryant Ranch Prepack | 19 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 June 1964 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Aminocaproic acid
Clinical summary
Aminocaproic acid is an antifibrinolytic agent. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Aminocaproic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Aminocaproic acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Aminocaproic Acid prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Aminocaproic acid 0.25 g/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.